MedPath

JORDANIAN ROYAL MEDICAL SERVICES

🇯🇴Jordan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

3 Phases

Phase 2:1
Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 3
1 (33.3%)

Intramuscular Ketamine Effect on Postnasal Surgery Agitation

Phase 2
Completed
Conditions
Agitation, Emergence
Interventions
First Posted Date
2022-04-06
Last Posted Date
2023-01-25
Lead Sponsor
Jordanian Royal Medical Services
Target Recruit Count
193
Registration Number
NCT05313659
Locations
🇯🇴

Jordanian Royal Medical Services, Amman, Jordan

Bone Graft Cultivation by Periosteal Elevation

Phase 3
Conditions
Periosteal Elevation
First Posted Date
2022-03-08
Last Posted Date
2022-03-21
Lead Sponsor
Jordanian Royal Medical Services
Target Recruit Count
18
Registration Number
NCT05270317
Locations
🇯🇴

Royal Medical Services, Amman, Jordan

Midazolam Effect on Agitation Postnasal Surgery

Not Applicable
Completed
Conditions
Agitation
Interventions
Drug: Intravenous midazolam before emergence from general anesthesia
Drug: Intravenous normal saline before emergence from general anesthesia
First Posted Date
2021-12-21
Last Posted Date
2021-12-21
Lead Sponsor
Jordanian Royal Medical Services
Target Recruit Count
100
Registration Number
NCT05165914
Locations
🇯🇴

Royal Medical Services, Amman, Jordan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.